Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Illumina's Accelerator Program

Premium

Illumina has launched its Accelerator Program, a business accelerator that will focus on speeding up the time to market and lowering barriers to entry for individuals and start-ups that are developing next-generation sequencing applications.

Illumina will invite participants to a six-month program, where it will provide technology and business guidance as well as $100,000 in support, including access to sequencing systems and reagents and laboratory space at facilities in San Francisco. Initial investors include Yuri Milner and Silicon Valley Bank.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.